Tobira Therapeutics (TBRA) PT Cut to $19 at Cantor Fitzgerald; Keeps 'Buy'
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros slashed his price target on Tobira Therapeutics (NASDAQ: TBRA) to $19.00 (from $27.00) but maintained ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
